The Asia-Pacific immunochemistry market is expected to reach US$ 795.05 Mn in 2027 from US$ 436.79 Mn in 2019. The market is estimated to grow with a CAGR of 7.8% from 2019-2027.
The growth of the market is driven by the factors such as, rising incidences of chronic and infectious diseases and increasing geriatric population. However, the market is likely to slower down its growth due to the limitations associated with immunohistochemistry.
The countries in the region are creating significant opportunities for the key market players to expand their business. It is likely to be a major factor contributing to the market growth during the coming years. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope.
Also, the rising advancements in the biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in a developing nation.
The increasing investments in R&D activities have paved the way for the growth of the industry in the future years. Many scientists, in partnership with other scientists in China, offer various products for bioreactors. For instance, in April 2018, BIO attended meetings with members of the Chinese biotech community and government leaders. The conference aims the commitment on behalf of the western biotechnology industry for encouraging China to strengthen its support for biotech innovation. They aim to and take steps to enhance more significant investment and collaboration with companies in China. Thus, the rising number of infectious disease incidences and advancements are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the Immunochemistry Equipment Market during the forecast period.
The China is expected to lead the market in the Asia-Pacific region owing to the rapidly increasing incidence of chronic diseases like cancer in the country and the growing demand for diagnostics. Furthermore, the increasing prevalence of diabetes is also likely to grow the Immunochemistry Equipment Market. Therefore, considering the above-mentioned factors, the growth of the market in the country is expected to contribute the largest share in the Asia-Pacific region during the forecast period.
China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA-PACIFICIMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION
Asia-Pacific immunochemistry market Equipment Market - By Product
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Slide Scanners
- Other Equipment
- Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Stabilizers
- Solvents
- Proteolytic Enzymes
- Kits
Asia-Pacific immunochemistry market Equipment Market - By Application
- Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
Asia-Pacific immunochemistry market Equipment Market - By End User
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
Asia-Pacific immunochemistry market Equipment Market - By Geography
North America
- US
- Canada
- Mexico
Company Profiles
- PerkinElmer, Inc.
- Abcam Plc
- Agilent Technologies,
- Bio SB
- Bio-Rad Laboratories, Inc.
- Cell Signalling Technology, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Product, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Asia-Pacific Immunochemistry Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia-Pacific Immunochemistry Market – Market Landscape
4.1 Overview
4.2 Market Segmentation
4.2.1 Asia-Pacific Immunochemistry Market – By Product
4.2.2 Asia-Pacific Immunochemistry Market – By Application
4.2.3 Asia-Pacific Immunochemistry Market – By End User
4.2.4 Asia-Pacific Immunochemistry Market – By Country
4.3 PEST Analysis
4.3.1 Immunohistochemistry Market – Asia Pacific PEST Analysis
5. Asia-Pacific Immunochemistry Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases in China
5.1.2 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies in APAC
5.2 Key Market Restraints
5.2.1 Limitations Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunochemistry Market – Asia-Pacific Analysis
6.1 Asia-Pacific Immunochemistry Market Revenue Forecasts and Analysis
6.2 Performance of Key Players
7. Asia-Pacific Immunochemistry Market Analysis – By Application
7.1 Overview
7.2 Asia-Pacific Immunochemistry Market, By Application, 2018 & 2027 (%)
7.3 Asia-Pacific Immunochemistry Market Revenue and Forecasts to 2027, By Application (US$ Mn)
7.4 Diagnostics
7.4.1 Overview
7.4.2 Asia-Pacific Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Cancer
7.4.3.1 Overview
7.4.3.2 Asia-Pacific Cancer Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Infectious Diseases
7.4.4.1 Overview
7.4.4.2 Asia-Pacific Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Autoimmune Diseases
7.4.5.1 Overview
7.4.5.2 Asia-Pacific Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Nephrological Diseases
7.4.6.1 Overview
7.4.6.2 Asia-Pacific Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Drug Testing
7.5.1 Overview
7.5.2 Asia-Pacific Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)
8. Asia-Pacific Immunochemistry Market Analysis – By Product
8.1 Overview
8.2 Asia-Pacific Immunochemistry Market, By Product, 2018 & 2027 (%)
8.3 Asia-Pacific Immunochemistry Market Revenue and Forecasts to 2027, By Product (US$ Mn)
8.3.1 Asia-Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 Asia-Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2.1 Asia-Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Antibodies Market
8.4.1 Overview
8.4.2 Asia-Pacific Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.3 Primary Antibodies
8.4.3.1 Overview
8.4.3.2 Asia-Pacific Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4 Secondary Antibodies
8.4.4.1 Overview
8.4.4.2 Asia-Pacific Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Equipment
8.5.1 Overview
8.5.2 Asia-Pacific Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.3 Slide Staining Systems
8.5.3.1 Overview
8.5.3.2 Asia-Pacific Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4 Tissue Microarrays
8.5.4.1 Overview
8.5.4.2 Asia-Pacific Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5 Slide Scanners
8.5.5.1 Overview
8.5.5.2 Asia-Pacific Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6 Other Equipment
8.5.6.1 Overview
8.5.6.2 Asia-Pacific Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Reagents
8.6.1 Overview
8.6.2 Asia-Pacific Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.3 Histological Stains
8.6.3.1 Overview
8.6.3.2 Asia-Pacific Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.4 Blocking & Fixation Reagents
8.6.4.1 Overview
8.6.4.2 Asia-Pacific Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.5 Chromogenic Substrates
8.6.5.1 Overview
8.6.5.2 Asia-Pacific Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.6 Stabilizers
8.6.6.1 Overview
8.6.6.2 Asia-Pacific Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.7 Proteolytic Enzymes
8.6.7.1 Overview
8.6.7.2 Asia-Pacific Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.8 Solvents
8.6.8.1 Overview
8.6.8.2 Asia-Pacific Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Kits
8.7.1 Overview
8.7.2 Asia-Pacific Kits Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia-Pacific Immunochemistry Market Analysis – By End User
9.1 Overview
9.2 Asia-Pacific Immunochemistry Market, By End User, 2018 & 2027 (%)
9.3 Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospital & Diagnostic Laboratories
9.4.1 Overview
9.4.2 Asia-Pacific Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Institutes
9.5.1 Overview
9.5.2 Asia-Pacific Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others End Users
9.6.1 Overview
9.6.2 Asia-Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Asia-Pacific Immunochemistry Market Revenue and Forecasts To 2027
10.1 Asia Pacific Immunohistochemistry Market Revenue and Forecasts To 2027
10.2 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.1 Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.2.1.1 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.2 Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.2.1 Asia Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.2.2 Asia Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.2.3 Asia Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.3 Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.4 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
10.2.5 Japan Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.5.1 Japan Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.5.2 Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.2.5.2.1 Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.5.3 Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.5.3.1 Japan Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.5.3.2 Japan Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.5.3.3 Japan Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.5.4 Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.6 China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6.1 China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6.2 China Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.2.6.2.1 China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.6.3 China Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.6.3.1 China Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.6.3.2 China Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.6.3.3 China Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.6.4 China Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.7 India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 India Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.2.7.2.1 India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.7.3 India Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.7.3.1 India Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.7.3.2 India Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.7.3.3 India Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.7.4 India Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.8 South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.1 South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.2.8.2.1 South Korea Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.8.3 South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.8.3.1 South Korea Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.8.3.2 South Korea Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.8.3.3 South Korea Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.8.4 South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.9 Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.2.9.2.1 Australia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.9.3 Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.9.3.1 Australia Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.9.3.2 Australia Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.9.3.3 Australia Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.9.4 Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Immunochemistry Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies done by the companies in the Market, 2018 (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Overview
12. Immunohistochemistry Market–Key Company Profiles
12.1 Bio SB
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product portfolio
12.1.5 SWOT ANALYSIS
12.1.6 Key Developments
12.2 Cell Signaling Technology, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product portfolio
12.2.5 SWOT ANALYSIS
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PerkinElmer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abcam Plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Agilent Technologies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
Table 1. Asia-Pacific Immunochemistry Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 2. Asia-Pacific Immunochemistry Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 3. Asia-Pacific Antibodies Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 4. Asia-Pacific Equipment Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 5. Asia-Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 6. Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 7. Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 8. Asia-Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 9. Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 10. Asia-Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. Asia-Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 12. Asia-Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 13. Asia-Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 14. US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 15. US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 16. US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 17. US Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 18. US Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 19. US Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 20. US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 22. Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 23. Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 24. Canada Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 25. Canada Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 26. Canada Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 27. Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 28. Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
Table 29. Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 30. Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 31. Mexico Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 32. Mexico Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 33. Mexico Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 34. Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 35. Organic Developments Done By Companies
Table 36. Inorganic developments done by Companies
Table 37. Glossary Of Terms, Immunochemistry Market
LIST OF FIGURES
Figure 1. Asia-Pacific Immunochemistry Market Overview
Figure 2. Diagnostics Segment Held Largest Share Of Application Segment In Immunochemistry Market
Figure 3. US is Expected To Show Remarkable Growth During The Forecast Period
Figure 4. Asia-Pacific Immunochemistry Market- Leading Country Markets (US$ Mn)
Figure 5. Immunochemistry Market Segmentation
Figure 6. Asia-Pacific PEST Analysis
Figure 7. Immunochemistry Market Impact Analysis of Drivers & Restraints
Figure 8. Asia-Pacific Immunochemistry Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 9. Prominent Players in the Immunohistochemistry Market
Figure 10. Asia-Pacific Immunochemistry Market, By Application, 2018 & 2027 (%)
Figure 11. Asia-Pacific Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Asia-Pacific Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Asia-Pacific Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Asia-Pacific Autoimmune Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Asia-Pacific Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Asia-Pacific Drug Testing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Asia-Pacific Immunochemistry Market, By Product 2018 & 2027 (%)
Figure 18. Asia-Pacific Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia-Pacific Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia-Pacific Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia-Pacific Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia-Pacific Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia-Pacific Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia-Pacific Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia-Pacific Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia-Pacific Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Asia-Pacific Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Asia-Pacific Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Asia-Pacific Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Asia-Pacific Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Asia-Pacific Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Asia-Pacific Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Asia-Pacific Kits Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Asia-Pacific Immunochemistry Market, By End User, 2018 & 2027 (%)
Figure 35. Asia-Pacific Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Asia-Pacific Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Asia-Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Asia-Pacific Immunohistochemistry Market Revenue Overview, by Country (2018) (US$ Mn)
Figure 39. Asia-Pacific Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Asia-Pacific Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
Figure 41. US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Growth Strategies done by the companies in the Market, 2018 (%)
The List of Companies - Asia Pacific Immunochemistry Equipment Market
- PerkinElmer, Inc.
- Abcam Plc
- Agilent Technologies,
- Bio SB
- Bio-Rad Laboratories, Inc.
- Cell Signalling Technology, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Immunochemistry Equipment Market
Mar 2020
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography